A carregar...
The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors
The FDA-approved antidepressant and smoking cessation drug bupropion is known to inhibit dopamine and norepinephrine reuptake transporters, as well as nicotinic acetylcholine receptors (nAChRs) which are cation-conducting members of the Cys-loop superfamily of ion channels, and more broadly pentamer...
Na minha lista:
| Publicado no: | Neuropharmacology |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5148637/ https://ncbi.nlm.nih.gov/pubmed/27671323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2016.09.021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|